Scientists: LSD And Magic Mushrooms For End-Of-Life Patients

YouTube
Hallucinogenic drugs sought provide non-Biblical answers to questions like who we are, why are we here and where are we going. Traditionally, Christianity has provided these answers. Technocrat scientists and physicians want to equip hospice caregivers with both psilocybin and LSD to deliver alternate answers to end-of-life patients. ⁃ TN Editor

Opiates are the drugs of choice in battling pain in the terminally ill, but opiates render such patients dull and unresponsive. Hallucinogens could well offer a better path.

The ’60s was the golden age of LSD research. The U.S. government subsidized at least 116 experiments (that we know of) over this interval to unlock its secrets. Dr. Stanislav Grof, one of the early experimenters, described LSD as a “non-specific amplifier of the unconscious,” for both good and bad. The suggestion was that LSD might be a primary modulator of the unconscious mind, and unlocking its mysteries would answer the questions of who we are, why we are here, and what’s to become of us. Big questions indeed. Maybe too big to be left to scientists?

As hard as you may try, you can’t keep something this big locked up in the lab. These molecules escaped from the ivory tower and started a (relatively) bloodless revolution within America, especially among young people, who were disillusioned with the U.S. government, and the handling of the Vietnam War and the civil rights movement. Psychedelics were all the rage in the late ’60s throughout the country. College campuses were the testing ground for this social experiment, and some still are.

Who on this earth is in greatest need of happiness, or at least the alleviation of the severest form of dysphoria or distress? Terminal cancer patients, that’s who. Standard hospice care provides such patients with opiates like hydromorphone (Dilaudid), which, while alleviating pain, dope them up to the point where they can’t and don’t care, and can’t even respond: they can’t tell their doctors that they are scared, or their loved ones that they love them. And of course these opiates are highly addictive. You could argue: Who cares about addiction if you’re already dying? Both of my parents died in hospice care, both doped up on opiates at the end. I couldn’t tell them I loved them, and they couldn’t communicate back. Prescribing opiates is more humane than letting patients suffer but nonetheless not an optimal way to depart this world. We all deserve a better exit than that, at peace with our own imminent mortality.

In a study that took a full decade to complete, and with the approval of the FDA, NIH, DEA, and a host of institutional review boards, Charles Grob at Harbor-UCLA Medical Center assessed the use of psilocybin (the compound in “magic mushrooms”) as a stand-alone treatment for the reactive anxiety and depression that attends death due to terminal cancer. In an initial study, 12 individuals with a life-threatening cancer diagnosis participated in a double-blind randomized crossover fashion (neither the subject nor the physician knew which treatment was being administered) with either psilocybin or niacin (Vitamin B3), which results in a tingling sensation and acted as the placebo control. Furthermore, every subject was prepared by a licensed psychologist beforehand to minimize the possibility of any side effects or a bad trip. Each had their own personalized metaphysical tour guide, who remained with them through the session. They optimized the set and the setting by providing a pleasing and comfortable environment. These clinical research studies were carefully performed and documented, and above reproach. The results were quite remarkable. Feelings of “oceanic boundlessness” and “visionary restructuralization” were followed by positive mood and reduction in depressive scores, which persisted up to six months after the psilocybin treatment ended.

In a study that took a full decade to complete, and with the approval of the FDA, NIH, DEA, and a host of institutional review boards, Charles Grob at Harbor-UCLA Medical Center assessed the use of psilocybin (the compound in “magic mushrooms”) as a stand-alone treatment for the reactive anxiety and depression that attends death due to terminal cancer. In an initial study, 12 individuals with a life-threatening cancer diagnosis participated in a double-blind randomized crossover fashion (neither the subject nor the physician knew which treatment was being administered) with either psilocybin or niacin (Vitamin B3), which results in a tingling sensation and acted as the placebo control. Furthermore, every subject was prepared by a licensed psychologist beforehand to minimize the possibility of any side effects or a bad trip. Each had their own personalized metaphysical tour guide, who remained with them through the session. They optimized the set and the setting by providing a pleasing and comfortable environment. These clinical research studies were carefully performed and documented, and above reproach. The results were quite remarkable. Feelings of “oceanic boundlessness” and “visionary restructuralization” were followed by positive mood and reduction in depressive scores, which persisted up to six months after the psilocybin treatment ended.

Read full story here…

Related Articles That You Might Like

Leave a Reply

avatar
  Subscribe  
Notify of
x
Follow Technocracy.News?

The only Authoritative source for

Exposing Technocracy

Stories curated daily from around the world

Subscribe and get the digest!

No SPAM! We will not share your email with any 3rd party.

Thank You for Subscribing!

 

If you don't receive a confirmation email within a few

minutes, please check  your spam/junk folder.

Wath for a confirmation email.